Saturday 17 October 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
56.09
1.69
−2.92%
Follow ATRC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 2.15% | (0.97%) | (2.40%) | (6.11%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 7 | 6 | 6 | |
| 1.64% | (0.74%) | (1.81%) | (4.60%) | ||
ROIC |
1.92% | (0.44%) | (1.48%) | (4.11%) | |
Return on Tangible Assets |
3.45% | (1.64%) | (4.09%) | (10.95%) | |
Average Days of Receivables |
51.25 | 47.14 | 45.51 | 44.35 | |
Free Cash Flow per Share |
1.09 | 1.11 | 1.01 | 0.69 | |
Free Cash Flow |
53.11 | 53.64 | 48.28 | 33.00 | |
Capital Expenditures |
(11.82) | (10.72) | (9.05) | (10.14) | |
| Other line items | |||||
Cash ROIC |
7.03% | 7.56% | 6.59% | 4.73% | |
Accounts Receivable Turnover |
7.80 | 8.20 | 8.42 | 8.79 | |
Accounts Payable Turnover |
4.39 | 4.83 | 5.31 | 4.55 | |
Inventory Turnover |
1.68 | 1.73 | 1.74 | 1.68 | |
Average Days of Payables |
96.92 | 82.81 | 69.07 | 71.38 | |
Days of Inventory on Hand |
226.89 | 219.88 | 214.20 | 221.25 | |
Tax Rate |
(0.13) | 0.41 | 0.13 | 0.03 | |
Research and Development Expense of Revenue |
17.21% | 18.28% | 18.56% | 21.16% | |
Selling, General and Administrative Expense of Revenue |
56.82% | 57.87% | 58.19% | 58.82% | |
Share Based Compensation of Revenue |
8.30% | 8.39% | 8.36% | 8.45% | |
Interest Coverage |
2.29 | (0.51) | (1.61) | (4.54) | |
Operating CF/Net income |
6.15 | (14.01) | (5.01) | (1.50) | |
Depreciation/Fixed assets |
0.50 | 0.53 | 0.54 | 0.52 | |
Capex/Depreciation |
(0.55) | (0.51) | (0.43) | (0.49) | |
Revenue per Share |
11.70 | 11.42 | 11.19 | 10.82 | |
Operating CF per Share |
1.33 | 1.33 | 1.20 | 0.90 | |
Capex per Share |
(0.24) | (0.22) | (0.19) | (0.21) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates